-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the launch of LabVantage Analytics, a full-featured, self-service advanced analytics solution that lets users easily explore, analyze, and visualize LIMS, enterprise, and external data to gain actionable business insights. Designed by analytics industry experts, LabVantage Analytics seamlessly integrates with all elements of the LabVantage LIMS platform, providing a single user interface and workflow.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, has appointed Mikael Hagstroem as Chief Executive Officer.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS. Adding validation support to a cloud-hosted, Software-as-a-Service (SaaS) LIMS increases confidence for organizations that function in regulated sectors, such as pharmaceuticals, biobanking, and clinical and molecular diagnostics.
Full story
-
Apr 6, 2021, 15:46 PM
by
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that the 8.6 edition of its flagship LIMS has been designed and tested to optimum cybersecurity standards.
Full story
-
Apr 6, 2021, 15:46 PM
by
Full story
-
Apr 6, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Researchers at the University of California (UC), San Diego have proposed that the definition of antibiotic resistance be broadened to include treatment failure among patients on appropriate antibiotic therapy, which still encompasses the “great majority of unsuccessful outcomes in infectious disease.
Full story
-
Apr 5, 2021, 14:45 PM
by
Earlier this month, MedAI announces to have integrated its drug research and development platform for the pharmaceutical industry. The company is specialized in AI-assisted R&D and it now provides a wide range of solutions that covers nearly every stage of early drug development, including developing drug targets, biomarker discovery, chemical drug development, protein/antibody development, prediction of drug, crystal form, ADMET prediction, repurposing existing drugs, drug formulation development.
Full story
-
Apr 5, 2021, 14:45 PM
by
Kiniciti, a Welsh, Carson, Anderson & Stowe (“WCAS”) platform company that invests in non-therapeutic companies supporting Cell and Gene Therapy innovation, announced the formation of an Advisory Board and appointment of two inaugural members: Denis Bedoret, PhD, chief executive officer of Imcyse, and Andrew Knudten, chief operating officer of Jaguar Gene Therapy.
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:45 PM
by
Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, announces Qlucore Omics Explorer (QOE) version 3.7, an extensive upgrade adding features in many different areas to strengthen visual analysis support even further.
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:45 PM
by
Bioinformatics methods suffer from a significant loss of accuracy when used on sequencing data from under-represented populations because the genetic information of such populations cannot be captured in the linear reference genome. The inherent bias in the industry’s current reference genome favors the European population. A pan-genome approach can provide significant improvements, but it is still suboptimal. The Seven Bridges GRAF Population Solution is ancestry-aware and, therefore, more accurate than both linear and pan-genome approaches.
Full story
-
Apr 5, 2021, 14:45 PM
by
Full story
-
Apr 5, 2021, 14:43 PM
by
Full story
-
Apr 5, 2021, 14:43 PM
by
Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times.
Full story
-
Apr 5, 2021, 14:43 PM
by
ENDURADRIVE® Fan System provides peace of mind and unmatched reliability, thanks to its advanced design
Full story
-
Apr 5, 2021, 14:43 PM
by
Full story
-
Apr 5, 2021, 14:43 PM
by
Commit, the leading Israeli-based global tech and custom software solutions firm is expanding into North America.
Full story
-
Apr 5, 2021, 14:43 PM
by
Full story
-
Apr 5, 2021, 14:43 PM
by
CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.
Full story